Anti-infective agents are drugs used
for the purpose of killing and/or suppressing the infection causing organisms
from invading the host organism by means of its replication or releasing
variety of toxins in the host. Such infection causing micro-organisms include
viruses, bacteria, fungi, viroids and macro parasites. Infections thus caused
can be classified depending on the type of organism causing infection and the
symptoms and medical signs shown by host.
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/anti-infectives-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018
The global market for
anti-infectives is classified by product type as antifungal, antiviral and
antibacterial depending on the type of organism they fight. Geographically,
North America is the most dominating region in the anti-infectives market and
is followed by Europe. The emerging economies of Asia-Pacific regions are also
showing growth potential in the global anti-infectives market. India forecasts
high potential for growth in demand for anti-infectives due to existence of
large patient pool, the government initiatives of undertaking various control
programs and private partnership projects and rising cost containment
initiatives by drug manufacturers.
Some of the major driving factors
for the anti-infectives market include increase in patient population, large
number of vaccines gaining approvals and newer drug introductions. The growing
resistance of infection causing organisms to the existing drug therapies could
pose a major challenge to the anti-infectives market. Furthermore, high price
of drugs, dicey reimbursement policies and competition between generic
manufacturers may hold back the growth of this market. The anti-infectives
market is highly fragmented with a large number of domestic and international
players. Developmental focus of anti-infective agents has shifted to antiviral
agents due to requirement of longer treatment regimens in large number of patient
population with chronic indications as compared to antifungal and antibacterial
agents requiring shorter treatments.
Contact
M/s Sheela
90 Sate Street, Suite
700
Albany, NY 12207
USA – Canada Toll
Free: 866-997-4948
No comments:
Post a Comment